Skip to main content
OpenTrials

Clinical trial condition

Myositis Ossificans

Explore clinical trials studying Myositis Ossificans. Study availability and eligibility vary by location and protocol.

19 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Myositis Ossificans trial results

Completed

A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva

NCT03188666

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +2 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Vanderbilt University Nashville, Tennessee, United States
  • Toronto General Hospital Toronto, Ontario, Canada
View Trial Details
Completed

An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects

NCT02190747

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California San Francisco, Division of Endocrinology and Metabolism San Francisco, California, United States
  • University of Pennsylvania, Center for Research in FOP & Related Disorders Philadelphia, Pennsylvania, United States
  • Hôpital Necker-Enfants Malades, Department of Genetics Paris, France
  • The Royal National Orthopaedic Hospital, Brockley Hill Stanmore, Middlesex, United Kingdom
View Trial Details
Completed

A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)

NCT02322255

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California San Francisco, Division of Endocrinology and Metabolism San Francisco, California, United States
  • University of Pennsylvania, Center for FOP & Related Bone Disorders Philadelphia, Pennsylvania, United States
  • Hospital Italiano de Buenos Aires, Department of Pediatrics Buenos Aires, Argentina
  • Queensland University of Technology (QUT) Institute of Health and Biomedical Innovation (IHBI) Woolloongabba, Queensland, Australia
View Trial Details
Active, Not Recruiting

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT05394116

Conditions
Fibrodysplasia Ossificans Progressiva, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations
  • University of California Los Angeles (UCLA) Medical Center Los Angeles, California, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Hospital Israelita Albert Einstein São Paulo, Brazil
View all 22 locations
View Trial Details
Active, Not Recruiting

A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT06508021

Conditions
Fibrodysplasia Ossificans Progressiva, Foot Deformities, Hallux Valgus, +10 more
Locations
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Pennsylvania - Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions